Analysis of retinal sublayers in patients with systemic COVID-19 illness with varying degrees of severity.

Publication date: Jan 22, 2025

COVID-19 infection has been linked to ocular involvement, particularly retinal microvascular changes. Additionally, prolonged hypoxemia may affect retinal sublayers located within the retinal watershed zone. The aim of this study was to evaluate retinal and optic nerve OCT parameters in patients with COVID-19 illness of varying severity and compare them with controls. In this prospective case-control study, a total of 78 consecutive patients who had recently recovered from SARS-CoV-2 infection (29 outpatients, 32 ward-admitted patients, and 17 ICU-admitted patients) were included, along with 85 controls. All participants had no ocular disease or symptoms. Spectralis SD-OCT scans of the macula and optic nerve were obtained from all participants 6 weeks after initial diagnosis. The central subfield thickness of the macula (CSFT), peripapillary retinal nerve fiber layer thickness (pRNFL), and retinal sublayers’ volumes in the total 6-mm ETDRS zone were recorded and analyzed using the ANCOVA test, adjusting for age. The mean CSFT in controls was 271 μm, while in the outpatient, ward-admitted, and ICU-admitted groups, it was 251, 260, and 253 μm, respectively (P = 0. 093). No differences were observed in pRNFL between the groups (P> 0. 1). However, the outer plexiform layer (OPL) was the only retinal sublayer that demonstrated a significant difference in 6-mm volume across the groups, with volumes of 0. 832 μm in controls, 0. 822 μm^3 in the outpatients, 0. 814 μm^3 in ward-admitted patients, and 0. 785 μm^3 in ICU-admitted cases (P = 0. 006). Our findings suggest that patients with severe COVID-19 illness, especially those requiring respiratory support, may develop ischemia and atrophy of the OPL. This indicates that the OPL might be the most vulnerable retinal sublayer to systemic hypoxemia, a hypothesis that requires confirmation through future studies.

Open Access PDF

Concepts Keywords
785m Adult
Oct Aged
Outpatients Case-Control Studies
Retinal COVID-19
Watershed COVID-19
Female
Humans
Hypoxemia
Macula Lutea
Male
Middle Aged
Optic Nerve
Optical coherence tomography
Outer plexiform layer
Prospective Studies
Retina
SARS-CoV-2
Tomography, Optical Coherence

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH hypoxemia
pathway REACTOME SARS-CoV-2 Infection
disease MESH ischemia
disease MESH atrophy
disease MESH morbidity
disease MESH complications
disease MESH cytokine storm
disease IDO host
drug DRUGBANK Oxygen
drug DRUGBANK Coenzyme M
disease IDO history
disease MESH cataract
disease MESH glaucoma
disease MESH age related macular degeneration
disease MESH retinal vein occlusion
disease MESH uveitis
disease MESH refractive errors
disease MESH asthma
pathway KEGG Asthma
disease MESH Alzheimer’s disease
disease MESH emergency
disease IDO facility
disease MESH edema
disease MESH common cold
disease IDO blood
disease MESH myopia
disease MESH hyperopia
disease MESH Diabetic Retinopathy
disease MESH ganglion
drug DRUGBANK Methionine
disease MESH syndrome
disease MESH central serous chorioretinopathy
disease MESH central retinal artery occlusion
disease MESH acute macular neuroretinopathy
disease MESH optic neuritis
disease MESH papilledema
disease MESH Long COVID
drug DRUGBANK Guanosine
disease MESH relapse
disease MESH thrombosis
drug DRUGBANK Sulodexide
disease MESH retinal disease
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)